Last updated on October 2019

A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Patients With Motor Fluctuations


Brief description of study

To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) extended-release capsules (IPX203 ER CD-LD) in comparison to immediate release (IR) CD-LD in the treatment of CD-LD-experienced subjects with Parkinson's disease (PD) who have motor fluctuations.

 

Clinical Study Identifier: TX228693

Find a site near you

Start Over

Neurotrials Research, Inc.

110 Johnson Ferry Road NE Atlanta, GA United States
  Connect »